Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid nanoparticle-mediated drug delivery to the brain
Purva Khare, Sara X. Edgecomb, Christine M. Hamadani, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114861-114861
Closed Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
Liusheng Wu, Xiaoqiang Li, Xinye Qian, et al.
Vaccines (2024) Vol. 12, Iss. 2, pp. 186-186
Open Access | Times Cited: 53
Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment
Changhong Zhao, Xinshu Zhu, Jianmei Tan, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116113-116113
Open Access | Times Cited: 20
Predictive High-Throughput Platform for Dual Screening of mRNA Lipid Nanoparticle Blood–Brain Barrier Transfection and Crossing
Emily L. Han, Marshall S. Padilla, Rohan Palanki, et al.
Nano Letters (2024) Vol. 24, Iss. 5, pp. 1477-1486
Closed Access | Times Cited: 19
Ionic liquids revolutionizing biomedicine: recent advances and emerging opportunities
Yanhui Hu, Yuyuan Xing, Hua Yue, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 20, pp. 7262-7293
Open Access | Times Cited: 31
SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun, Xiaorui Xing, Huanyu Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115586-115586
Open Access | Times Cited: 31
Circular mRNA Vaccine against SARS-COV-2 Variants Enabled by Degradable Lipid Nanoparticles
Ke Huang, Na Li, Yingwen Li, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Yuanke Li, Ruiying Liu, Zhen Zhao
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 109-109
Open Access
Iron oleate containing lipid nanoparticles prepared by gradient solvent diffusion method for oxidative stress dependent antibacterial therapy
Yujie Zhou, Zihui Yan, Qianya Wang, et al.
International Journal of Pharmaceutics (2025), pp. 125264-125264
Closed Access
Recent advances in the development of sialyltransferase inhibitors to control cancer metastasis: A comprehensive review
Ranim Al Saoud, Amar Hamrouni, Adi Idris, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115091-115091
Open Access | Times Cited: 18
Recent Uses of Lipid Nanoparticles, Cell-Penetrating and Bioactive Peptides for the Development of Brain-Targeted Nanomedicines against Neurodegenerative Disorders
Yu Wu, Angelina Angelova
Nanomaterials (2023) Vol. 13, Iss. 23, pp. 3004-3004
Open Access | Times Cited: 15
Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics
Patrick T. Ronaldson, Thomas P. Davis
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 1, pp. 71-89
Closed Access | Times Cited: 5
Nanomaterials Boost CAR‐T Therapy for Solid Tumors
Jun Long, Yian Wang, Xianjie Jiang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 20
Closed Access | Times Cited: 5
Peptide-Hitchhiking for the Development of Nanosystems in Glioblastoma
Francisco Branco, Joana Cunha, Maria Mendes, et al.
ACS Nano (2024) Vol. 18, Iss. 26, pp. 16359-16394
Open Access | Times Cited: 5
Advances in local drug delivery technologies for improved rheumatoid arthritis therapy
Xiaoran An, Jiapei Yang, Xiaolin Cui, et al.
Advanced Drug Delivery Reviews (2024) Vol. 209, pp. 115325-115325
Closed Access | Times Cited: 4
Strategies for enhanced gene delivery to the central nervous system
Zhenghong Gao
Nanoscale Advances (2024) Vol. 6, Iss. 12, pp. 3009-3028
Open Access | Times Cited: 3
Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery
Jialiang Wang, Yaopeng Ding, K. Chul Chong, et al.
Vaccines (2024) Vol. 12, Iss. 10, pp. 1148-1148
Open Access | Times Cited: 3
Lipoplexes’ Structure, Preparation, and Role in Managing Different Diseases
Sally A. El‐Zahaby, Lovepreet Kaur, Ankur Sharma, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Closed Access | Times Cited: 3
Liposomal Nanomaterials: A Rising Star in Glioma Treatment
Yu Gan, Yingying Yu, Huizhe Xu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 6757-6776
Open Access | Times Cited: 3
Trajectory of brain-derived amyloid beta in Alzheimer’s disease: where is it coming from and where is it going?
Ni Liu, Anaer Haziyihan, Wei Zhao, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
The piper at the gates of brain: A systematic review of surface modification strategies on lipid nanoparticles to overcome the Blood-Brain-Barrier
Ronny Vargas, Catalina Lizano-Barrantes, Miquel Romero-Obón, et al.
International Journal of Pharmaceutics (2024), pp. 124686-124686
Open Access | Times Cited: 3
Enhancing paracellular and transcellular permeability using nanotechnological approaches for the treatment of brain and retinal diseases
Asmaa Khalil, Alexandre Barras, Rabah Boukherroub, et al.
Nanoscale Horizons (2023) Vol. 9, Iss. 1, pp. 14-43
Open Access | Times Cited: 8
TET1-Lipid Nanoparticle Encapsulating Morphine for Specific Targeting of Peripheral Nerve for Pain Alleviation
Hongmei Yang, Zhongqi Liu, Fan Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 4759-4777
Open Access | Times Cited: 2
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Endothelial cell‐specific reduction in mTOR ameliorates age‐related arterial and metabolic dysfunction
Md Torikul Islam, Shelby A. Hall, Tavia Dutson, et al.
Aging Cell (2023) Vol. 23, Iss. 2
Open Access | Times Cited: 7
Emerging Strategies for Immunotherapy of Solid Tumors Using Lipid‐Based Nanoparticles
Soraia Fernandes, Marco Cassani, Francesca Cavalieri, et al.
Advanced Science (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top